updat hsic/cvet sotp reflect
increment detail
spinco investor meet nyc specif point baselin adj
ebitda incl public co cost expect
grow double-digit annual revis ebitda forecast
sotp-bas pt move factor
financi highlight investor day
management present compel intro spinco strategi valu proposit
channel initi financi outlook financi highlight adj ebitda
compar ytd excl non-transf corp overhead --
think slightli higher initi read factor
plan public co cost translat baselin adj ebitda
ytd organ growth incl roadrunn deal
cost invest incur certain duplic cost plan tsa
transit first two yr also expect one-tim outlay first
three yr tie standard core hr suppli chain might
capital-expenditure vs opex assum exclud non-gaap
capit alloc focu pay debt lt goal reach ig leverag
target vs spin
synergi re-affirmed expect ebit run-rat synergi
mostli increment rev includ exit exit
point rev line market growth think msd
ebitda growth baselin long term expect hsd revenue growth
 doubl digit ebitda growth assum adj effect tax
tweak sotp model pt
-- trim ebitda forecast
primarili reflect lower nt profit vet first choic
public co cost revis sotp assum trade ebitda
translat equiti valu equal per share valu
per share premium elan/zt discount
go-forward -- ebitda forecast mostli
unchang assum trade ebitda discount
histor ftm average premium analysi factor
net proce share sale top dividend
roll peg remainco valu think pace magnitud
capit deploy post-spin main wildcard
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
globally-focus distributor serv individu
dental medic veterinari practition well-
posit deliv consist revenu earn growth
like hsic competit posit calib senior
howev remain cautiou on-going consolid
side proverbi hourglass supplier
customers/dso think gener econom
histor accru channel appear increasingli
at-risk especi light recent file pend ftc
dental cad/cam market share gain us new siro
market share gain medic
price base sotp use ebitda
valu valu
share repurchas
price assum trade ebitda
deterior dental util trend amer eu vet
advers outcom file ftc anti-trust suit profit
price base ebitda
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
pleas see import disclosur inform page report
lead multi-n distributor healthcar product servic office-bas practition includ
dental practition laboratori physician practic anim health clinic world-wide
pt repres horizon dcf impli sotp valuat discount back risk competit
brandon couillard certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
matthew stanton certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
michael koban certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
